Cytisinicline to Speed Smoking Cessation in the United States
JAMA · 2023
DOI: 10.1001/jama.2023.5939 ↗Kurz gefasst
Editorial in der Zeitschrift JAMA, 2023. Verfasst von Jonathan Foulds und 2 weiteren Autor:innen. Beteiligte Einrichtung: Penn State Center for Research on Tobacco and Health, Department of Public Health Sciences, Penn State College of Medicine, Hershey, Pennsylvania. Hauptthemen laut MEDLINE: Cigarette Smoking, Quinolizidine Alkaloids, Smoking Cessation, Smoking Cessation Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Penn State Center for Research on Tobacco and Health, Department of Public Health Sciences, Penn State College of Medicine, Hershey, Pennsylvania.
Förderung
- NIDA NIH HHS
Zitieren
APA
Foulds, J., Allen, S. I., & Yingst, J. (2023). Cytisinicline to Speed Smoking Cessation in the United States. JAMA. https://doi.org/10.1001/jama.2023.5939
Vancouver
Foulds J, Allen SI, Yingst J. Cytisinicline to Speed Smoking Cessation in the United States. JAMA. 2023. doi:10.1001/jama.2023.5939
BibTeX
@article{Foulds2023,
author = {Foulds, Jonathan and Allen, Sophia I and Yingst, Jessica},
title = {Cytisinicline to Speed Smoking Cessation in the United States},
journal = {JAMA},
year = {2023},
doi = {10.1001/jama.2023.5939}
}
EUVIMED